Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

160JPY
6:00am GMT
Change (% chg)

¥-1 (-0.62%)
Prev Close
¥161
Open
¥161
Day's High
¥166
Day's Low
¥160
Volume
989,600
Avg. Vol
1,672,384
52-wk High
¥395
52-wk Low
¥118

Latest Key Developments (Source: Significant Developments)

Solasia Pharma says new share prices
Wednesday, 5 Sep 2018 

Sept 5 (Reuters) - Solasia Pharma KK <4597.T>:Says it will issue new shares via public offering, with the issue price of 237 yen per share(3.5 billion yen in total) and paid-in price of 222.3 yen per share (3.29 billion yen in total) .Subscription period from Sept. 6 to Sept. 7 and payment date on Sept. 12 .Says it will issue new shares via private placement, with the paid-in price of 222.3 yen per share (up to 492.9 million yen in total) .Subscription date on Oct. 10 and payment date on Oct. 11 .  Full Article

Pledpharma and Solasia enter license agreement on Pledox in Asia
Monday, 20 Nov 2017 

Nov 20 (Reuters) - PLEDPHARMA AB (PUBL) :PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA .PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY UPFRONT, DEVELOPMENT, REGULATORY AND SALES MILESTONES OF UP TO ABOUT USD 83 MILLION​.PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY INDUSTRY STANDARD ROYALTY RATES ON SALES​.PLEDPHARMA AB (PUBL) - ‍WILL ALSO FULLY FINANCE AN EXPANSION OF PHASE III PROGRAM FOR PLEDOX​.‍TOTAL VALUE OF UPFRONT AND MILESTONE PAYMENTS IS UP TO JPY 9.3 BILLION​.‍PHASE III STUDIES ANTICIPATED TO BE INITIATED END OF 2017 WITH TOP LINE RESULTS EXPECTED IN 2020​.  Full Article